Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities w...
Autors principals: | Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Elsevier
2018
|
Ítems similars
-
Modeling Fragile X Syndrome in Drosophila
per: Małgorzata Drozd, et al.
Publicat: (2018-04-01) -
Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
per: Alessandra Tempio, et al.
Publicat: (2023-04-01) -
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
per: Thomas Maurin, et al.
Publicat: (2018-12-01) -
A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
per: Tovi Anderson, et al.
Publicat: (2013-01-01) -
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
per: Sara Castagnola, et al.
Publicat: (2017-11-01)